Every day, researchers are working to get a better understanding of celiac disease and its various presentations. Ongoing research is also exploring potential drug treatments for celiac disease. To view all information related to drug development and research, please visit our main celiac disease research page. Learn about the Beyond Celiac Science Department here.
In the digital age, it’s easy for information to get lost in the flood of a feed. To catch you up to speed, we’re sharing the top celiac disease research stories of 2024, based on visits from community members like you.
When you are diagnosed with celiac disease at 60 years or more, your chance of being frail increases both before and after diagnosis, according to a recent study.
Only 10 percent of nearly 224,000 children who had a symptom or condition that should have led to celiac disease testing were actually tested, Beyond Celiac research found.
Beyond Celiac recently presented three posters that provide evidence that screening for celiac disease is not taking place as often as it should, that neurological symptoms are frequent and severe and that those with celiac disease are often exposed to gluten, which impacts their social interactions and work.
Beyond Celiac and the American Gastroenterological Associate partnered to bring important updates in celiac disease research, management and more to patients through patient-friendly summaries of recent articles published by AGA.
For those with celiac disease, an endoscopy and biopsy may not be a major barrier to participating in clinical trials and intestinal healing is an important result when celiac disease patients consider potential treatments, Beyond Celiac research finds.
Nearly one in four non-Hispanic Black Americans who have conditions that should lead to a test for celiac disease never get one, according to data presented by Beyond Celiac at the International Celiac Disease Symposium.
The answers to how and where the response to gluten in celiac disease begins have been found in the single layer of cells that line the small intestine, according to new research led by McMaster University researchers.
Who’s missing in celiac disease diagnosis and what patients want in clinical trials among Beyond Celiac topics to be presented at upcoming international celiac disease meeting in Sheffield, UK.
A new study that analyzed the activity of more than 10,000 genes found that a drug being investigated to treat celiac disease prevented intestinal damage caused by gluten.
Studies of both children and adults suggest that highly positive TTG-IgA test results might be enough for a celiac disease diagnosis.
Obesity was more common in those with celiac disease compared to those without celiac disease, analysis of a large national database of health information found.
Increased amounts of gluten in a gluten challenge for those on a gluten-free diet may be needed for accurate celiac disease blood tests done as part of diagnosis.
More than half of children with celiac disease did not get recommended blood test follow-ups in a study that used artificial intelligence to scan electronic health records.
Children diagnosed with celiac disease often neglect follow-up as they reach adulthood, study shows.
Increased doses of a drug being studied for the treatment of celiac disease tempered the response to gluten in celiac disease patients and remained as safe and well tolerated as lower doses.
Overall, about 30 percent of people who have had a positive blood test for celiac disease don’t go on to get a confirming endoscopy and biopsy, Beyond Celiac research presented at DDW found.
Nearly one in three people who have positive blood tests for celiac disease don’t go on to get the endoscopy and biopsy that confirms a celiac disease diagnosis, according to new research by Beyond Celiac.
Children who most likely would not have been diagnosed with celiac disease had they not been randomly screened for the condition showed important health-related improvements after diagnosis and one year on the gluten-free diet.
Physicians' common view that celiac disease is rare in Black Americans can lead to disparity in testing for the condition, according to the study, published recently as a research letter in the journal, Gastro Hep Advances.
Recently, a group of researchers published their recommendations for standardizing celiac disease clinical trials. While on the whole we agree with the content, we were dismayed to learn that no patients or patient organizations had been consulted to develop these guidelines. We are proud to say that our response, a letter to the editor, was recently published in Gastroenterology.
If a child at risk for celiac disease is prescribed antibiotics multiple times, it may increase the chance that celiac disease will develop, according to a new study. Antibiotics were tied to an increase in a protein that loosens the connection between cells in the intestine. In the future, tests for that protein might be used to determine who is likely to develop celiac disease.
A higher income, living in an urban area and living close to a celiac disease center are all positively correlated with celiac disease prevalence, while being Black or Latino/Hispanic is negatively correlated, according to our research poster presented at Digestive Disease Week 2023.
This new phase 1 trial does not include a gluten challenge
A recent study found that children who had detectable gluten in urine and stool samples did not have symptoms, backing up earlier evidence that symptoms are not reliable indicators of gluten getting into the gluten-free diet.
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to
